Research Article
CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
Table 3
Multivariate analysis for overall survival of enrolled COAD cohort.
| Variables | HR | 95% CI | value |
| Age (years) | ≤65 | Reference | | | >65 | 2.489 | 1.337–4.632 | | T stage | T1 | Reference | | | T2 | 0.982 | 0.337–2.861 | 0.974 | T3 | 1.098 | 0.460–2.621 | 0.834 | T4 | 3.108 | 1.123–8.600 | | Lymph node status | Negative | Reference | | | Positive | 2.853 | 1.501–5.424 | | Chemotherapy | No or unknown | Reference | | | Accepted | 0.339 | 0.165–0.695 | | CSRP1 protein level | Low | Reference | | | High | 1.895 | 1.078–3.330 | |
|
|